Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV autologous bone marrow mesenchymal stem cells for chronic brain injury (STR01-08)
jRCT1090220333Phase 2Recruiting
- Sponsor
- Osamu Honmou, MD, PhD
- Start
- Feb 2018
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of autologous bone marrow derived mesenchymal stromal cells in chronic traumatic encephalopathy (CTE), sponsored by Osamu Honmou, MD, PhD. Started Feb 2018; status: recruiting.
02
Drugs
autologous bone marrow derived mesenchymal stromal cells
03
Conditions
chronic traumatic encephalopathy (CTE)
Beyond the preview
Go deeper on jRCT1090220333.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1090220333.